Inhibition/NN
of/IN
HIV-1/NN
latency/NN
reactivation/NN
by/IN
dehydroepiandrosterone/NN
(/(
DHEA/NN
)/)
and/CC
an/DT
analog/NN
of/IN
DHEA/NN
./.

The/DT
initial/JJ
infection/NN
with/IN
human/JJ
immunodeficiency/NN
virus/NN
type/NN
1/CD
(/(
HIV-1/NN
)/)
in/IN
most/JJS
individuals/NNS
usually/RB
results/VBZ
in/IN
the/DT
establishment/NN
of/IN
a/DT
latent/JJ
or/CC
chronic/JJ
infection/NN
before/IN
eventual/JJ
progression/NN
toward/IN
acquired/VBN
immunodeficiency/NN
syndrome/NN
./.
=====
HIV-1/NN
can/MD
also/RB
establish/VB
a/DT
latent/JJ
or/CC
persistent/JJ
infection/NN
in/IN
some/DT
T/NN
cell/NN
lines/NNS
that/WDT
show/VBP
minimal/JJ
constitutive/JJ
virus/NN
expression/NN
./.
=====
However/RB
,/,
activation/NN
of/IN
the/DT
T/NN
cell/NN
lines/NNS
leading/VBG
to/TO
enhanced/VBN
HIV-1/NN
replication/NN
can/MD
be/VB
induced/VBN
by/IN
antigens/NNS
,/,
mitogens/NNS
,/,
and/CC
cytokines/NNS
(/(
tumor/NN
necrosis/NN
factor/NN
alpha/NN
[/(
TNF-alpha/NN
]/)
,/,
interleukin/NN
1/CD
,/,
and/CC
interleukin-2/NN
)/)
./.
=====
Various/JJ
gene/NN
products/NNS
from/IN
other/JJ
viruses/NNS
(/(
HTLV-1/NN
,/,
HSV/NN
,/,
EBV/NN
,/,
CMV/NN
,/,
HBV/NN
,/,
and/CC
HHV-6/NN
)/)
can/MD
also/RB
enhance/VB
HIV-1/NN
long/JJ
terminal/JJ
repeat/NN
(/(
LTR/NN
)/)
-driven/JJ
reporter/NN
gene/NN
activity/NN
./.
=====
On/IN
the/DT
basis/NN
of/IN
these/DT
observations/NNS
,/,
it/PRP
has/VBZ
been/VBN
proposed/VBN
that/IN
reactivation/NN
of/IN
latent/JJ
HIV-1/NN
harbored/VBN
in/IN
chronically/RB
infected/JJ
T/NN
lymphocytes/NNS
,/,
monocytes/NNS
,/,
or/CC
macrophages/NNS
plays/VBZ
an/DT
important/JJ
role/NN
in/IN
the/DT
pathogenesis/NN
of/IN
AIDS/NN
./.
=====
So/RB
far/RB
,/,
there/EX
are/VBP
no/DT
drugs/NNS
or/CC
therapy/NN
available/JJ
that/WDT
can/MD
provide/VB
protection/NN
against/IN
HIV-1/NN
latency/NN
reactivation/NN
./.
=====
ACH-2/NN
,/,
derived/VBN
from/IN
a/DT
human/JJ
T/NN
cell/NN
line/NN
(/(
CEM/NN
)/)
,/,
is/VBZ
chronically/RB
infected/VBN
with/IN
HIV-1/NN
,/,
with/IN
low/JJ
levels/NNS
of/IN
constitutive/JJ
virus/NN
expression/NN
./.
=====
ACH-2/NN
can/MD
be/VB
converted/VBN
to/TO
productive/JJ
infection/NN
by/IN
stimulation/NN
of/IN
the/DT
cells/NNS
with/IN
12-O-tetradecanoylphorbol-13-acetate/NN
(/(
TPA/NN
)/)
,/,
mitogen/NN
or/CC
cytokines/NNS
(/(
TNF-alpha/NN
)/)
,/,
or/CC
infection/NN
with/IN
HSV/NN
./.
=====
Therefore/RB
the/DT
ACH-2/NN
cell/NN
line/NN
is/VBZ
a/DT
good/JJ
candidate/NN
for/IN
studying/VBG
the/DT
effects/NNS
of/IN
drugs/NNS
on/IN
HIV-1/NN
activation/NN
./.
=====
Previously/RB
,/,
we/PRP
have/VBP
reported/VBN
that/IN
DHEA/NN
and/CC
synthetic/JJ
analogs/NNS
of/IN
DHEA/NN
can/MD
be/VB
modest/JJ
inhibitors/NNS
of/IN
HIV-1/NN
IIIB/NN
replication/NN
in/IN
phytohemagglutinin-stimulated/JJ
peripheral/JJ
blood/NN
lymphocyte/NN
cultures/NNS
./.
=====
(/(
ABSTRACT/NN
TRUNCATED/VBN
AT/IN
250/CD
WORDS/NNS
)/)